Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.75 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.75 |
| ▸ | PRKCA | P17252 | 5/20 | 0.74 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.74 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.74 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.74 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL394036 | 1.00 | MAPT (0.75) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL9010956 | 1.00 | MAPT (0.75) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL10620809 | 1.00 | MAPT (0.75) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL7416016 | 1.00 | MAPT (0.75) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL16726792 | 1.00 | MAPT (0.75) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL3763399 | 1.00 | MAPT (0.75) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL9070261 | 1.00 | MAPT (0.75) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL9787451 | 1.00 | MAPT (0.75) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL10893167 | 1.00 | MAPT (0.75) | MAPTMAPK1PRKCAPRKCEPRKCQ | |
| SCHEMBL14952939 | 0.94 | PRKCA (0.67) | MAPTMAPK1PRKCAPRKCEPRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109640951-B | Preparation of microparticles of controlled size | 博莱科瑞士股份有限公司 | 2023-08-25 | — | — | CN | disclosed |
| CN-114269367-A | Therapeutic peptides | 科巴公司 | 2022-04-01 | — | — | CN | disclosed |
| CN-110478495-A | Target conjugate and its particle and preparation | TARVEDA THERAPEUTICS INC | 2019-11-22 | — | — | CN | disclosed |
| CN-106573077-B | Targeted conjugates and particles and formulations thereof | 塔弗达治疗有限公司 | 2019-07-30 | — | — | CN | disclosed |
| CN-110072883-A | The relevant peptide of therapeutic MOTS-C | 科巴公司 | 2019-07-30 | — | — | CN | disclosed |
| CN-104936622-A | Targeted conjugates encapsulated in particles and formulations thereof | BLEND THERAPEUTICS INC | 2015-09-23 | — | — | CN | disclosed |
| EP-0762899-A4 | STABILIZED HOMOGENOUS SUSPENSIONS AS COMPUTED TOMOGRAPHY CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP (US) | 1999-08-18 | — | — | EP | disclosed |
| EP-0762899-A1 | STABILIZED HOMOGENOUS SUSPENSIONS AS COMPUTED TOMOGRAPHY CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1997-03-19 | — | — | EP | disclosed |
| WO-1995032005-A1 | STABILIZED HOMOGENOUS SUSPENSIONS AS COMPUTED TOMOGRAPHY CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1995-11-30 | — | — | WO | disclosed |